House subcommittee passes bill to combat deadly synthetic drugs
The House Energy and Commerce Health Subcommittee today approved by voice vote the Synthetic Drug Control Act (H.R. 3537). The AHA-supported legislation would give the Drug Enforcement Administration authority to stop the distribution, sale and use of additional synthetic drugs by classifying them as Schedule I controlled substances. Since 2012, when 26 types of synthetic drugs were added to Schedule I, “many new synthetic substances have entered the market, leading to devastating health consequences and increased mortality, particularly among the nation’s youth,” AHA Executive Vice President Tom Nickels said in a letter of support for the bill.
Related News Articles
Headline
The National Collaborative for Improving the Clinical Learning Environment this week released guidance to help health care system leaders work with clinical…
Headline
In a letter this week, the AHA again urged the Centers for Medicare & Medicaid Services to take specific actions to address and prevent the serious…
Headline
The Centers for Medicare & Medicaid Services should continue to work with national standards body X12 to include the new unique device identifier on its…
Headline
The Centers for Disease Control and Prevention today issued recommendations to help health care providers and laboratories prevent the spread of Candida auris…
Headline
The New Jersey Hospital Association yesterday named as its next president and CEO Cathleen Bennett, an attorney who currently serves as commissioner of the New…
Headline
The Senate will not vote this week on a proposal by Sens. Lindsey Graham, R-S.C., Bill Cassidy, R-La., Dean Heller, (R-Nev., and Ron Johnson, R-Wis., to repeal…